Molecular Dynamics Simulations of the Adenosine A2a Receptor: Structural Stability, Sampling, and Convergence
暂无分享,去创建一个
[1] David Rodríguez,et al. Molecular dynamics simulations reveal insights into key structural elements of adenosine receptors. , 2011, Biochemistry.
[2] B. Hess,et al. Similarities between principal components of protein dynamics and random diffusion , 2000, Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics.
[3] Marta Filizola,et al. Dynamic models of G-protein coupled receptor dimers: indications of asymmetry in the rhodopsin dimer from molecular dynamics simulations in a POPC bilayer , 2006, J. Comput. Aided Mol. Des..
[4] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[5] Albert C. Pan,et al. Structure of the M3 Muscarinic Acetylcholine Receptor , 2012 .
[6] Bryan L. Roth,et al. Structure of the Nociceptin/Orphanin FQ Receptor in Complex with a Peptide Mimetic , 2012, Nature.
[7] H. Berendsen,et al. Interaction Models for Water in Relation to Protein Hydration , 1981 .
[8] Anat Levit,et al. Homology modeling of G-protein-coupled receptors with X-ray structures on the rise. , 2010, Current opinion in drug discovery & development.
[9] Thomas Williams,et al. Gnuplot 4.4: an interactive plotting program , 2010 .
[10] Gebhard F. X. Schertler,et al. Structure of a β1-adrenergic G-protein-coupled receptor , 2008, Nature.
[11] Xiao-dan Li,et al. Ligands stabilize specific GPCR conformations: but how? , 2012, Structure.
[12] R. Abagyan,et al. Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography. , 2010, Journal of the American Chemical Society.
[13] R. Stevens,et al. Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions , 2012, Science.
[14] Ron O. Dror,et al. High-resolution crystal structure of human Protease-Activated Receptor 1 bound to the antagonist vorapaxar , 2012, Nature.
[15] Maarten G. Wolf,et al. g_membed: Efficient insertion of a membrane protein into an equilibrated lipid bilayer with minimal perturbation , 2010, J. Comput. Chem..
[16] Alan Grossfield,et al. Quantifying uncertainty and sampling quality in biomolecular simulations. , 2009, Annual reports in computational chemistry.
[17] B. Hess. Convergence of sampling in protein simulations. , 2002, Physical review. E, Statistical, nonlinear, and soft matter physics.
[18] R. Millar,et al. Alanine-261 in intracellular loop III of the human gonadotropin-releasing hormone receptor is crucial for G-protein coupling and receptor internalization. , 1998, The Biochemical journal.
[19] René Meier,et al. Generation of a homology model of the human histamine H3 receptor for ligand docking and pharmacophore-based screening , 2007, J. Comput. Aided Mol. Des..
[20] T. Darden,et al. A smooth particle mesh Ewald method , 1995 .
[21] Carsten Kutzner,et al. GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.
[22] Laura López,et al. Progress in the structural prediction of G protein‐coupled receptors: D3 receptor in complex with eticlopride , 2011, Proteins.
[23] Thomas B Woolf,et al. Molecular dynamics simulation of dark-adapted rhodopsin in an explicit membrane bilayer: coupling between local retinal and larger scale conformational change. , 2003, Journal of molecular biology.
[24] Aashish Manglik,et al. Structure of the δ-opioid receptor bound to naltrindole , 2012, Nature.
[25] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.
[26] E. Bastia,et al. Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson's disease. , 2005, Pharmacology & therapeutics.
[27] Alan Grossfield,et al. Convergence of molecular dynamics simulations of membrane proteins , 2007, Proteins.
[28] Jonathan A. Javitch,et al. Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist , 2010, Science.
[29] Stephen Neidle,et al. Molecular dynamics and principal components analysis of human telomeric quadruplex multimers. , 2008, Biophysical journal.
[30] M. Congreve,et al. Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine. , 2011, Structure.
[31] J. Ballesteros,et al. Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. , 2002, The Journal of biological chemistry.
[32] Gerrit Groenhof,et al. GROMACS: Fast, flexible, and free , 2005, J. Comput. Chem..
[33] Daniel M Zuckerman,et al. On the structural convergence of biomolecular simulations by determination of the effective sample size. , 2007, The journal of physical chemistry. B.
[34] N. Aiyar,et al. G protein-coupled receptors in drug discovery. , 2003, Assay and drug development technologies.
[35] Tod D Romo,et al. Validating and improving elastic network models with molecular dynamics simulations , 2011, Proteins.
[36] M. Parrinello,et al. Canonical sampling through velocity rescaling. , 2007, The Journal of chemical physics.
[37] Jonathan S. Mason,et al. Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design , 2012, Journal of medicinal chemistry.
[38] M. Burghammer,et al. Crystal structure of the human β2 adrenergic G-protein-coupled receptor , 2007, Nature.
[39] A. Ivanov,et al. Molecular modeling and molecular dynamics simulation of the human A2B adenosine receptor. The study of the possible binding modes of the A2B receptor antagonists. , 2005, Journal of Medicinal Chemistry.
[40] S. Opella,et al. Structure of the Chemokine Receptor CXCR1 in Phospholipid Bilayers , 2012, Nature.
[41] O. Berger,et al. Molecular dynamics simulations of a fluid bilayer of dipalmitoylphosphatidylcholine at full hydration, constant pressure, and constant temperature. , 1997, Biophysical journal.
[42] A. Kruse,et al. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist , 2011, Nature.
[43] A. Amadei,et al. On the convergence of the conformational coordinates basis set obtained by the essential dynamics analysis of proteins' molecular dynamics simulations , 1999, Proteins.
[44] S. Rasmussen,et al. Structure of a nanobody-stabilized active state of the β2 adrenoceptor , 2010, Nature.
[45] J. Thornton,et al. PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .
[46] Q. Dong,et al. Overexpression of the A1 adenosine receptor in adipose tissue protects mice from obesity‐related insulin resistance , 2001, Diabetes, obesity & metabolism.
[47] Angus N R Nedderman,et al. Assessment of the absorption, metabolism and absolute bioavailability of maraviroc in healthy male subjects. , 2008, British journal of clinical pharmacology.
[48] M. Baaden,et al. Conformational sampling and dynamics of membrane proteins from 10‐nanosecond computer simulations , 2004, Proteins.
[49] W. Goddard,et al. Predicted structures of agonist and antagonist bound complexes of adenosine A3 receptor , 2011, Proteins.
[50] J. Drews. Drug discovery: a historical perspective. , 2000, Science.
[51] Jonathan S. Mason,et al. Progress in Structure Based Drug Design for G Protein-Coupled Receptors , 2011, Journal of medicinal chemistry.
[52] Francesca Fanelli,et al. Contributions of intracellular loops 2 and 3 of the lutropin receptor in Gs coupling. , 2008, Molecular endocrinology.
[53] S. Iwata,et al. G protein-coupled receptor inactivation by an allosteric inverse-agonist antibody , 2011, Nature.
[54] Albert C. Pan,et al. Structure and Dynamics of the M3 Muscarinic Acetylcholine Receptor , 2012, Nature.
[55] R. Paschke,et al. Role of the third intracellular loop for the activation of gonadotropin receptors. , 1999, Molecular endocrinology.
[56] R. Hauser,et al. Adenosine A2A Receptor Antagonists for Parkinson’s Disease , 2005, Drugs & aging.
[57] P. Fishman,et al. Antiinflammatory effect of A3 adenosine receptor agonists in murine autoimmune arthritis models. , 2005, The Journal of rheumatology.
[58] Michael Wiese,et al. Molecular dynamics simulation of the human adenosine A3 receptor: agonist induced conformational changes of Trp243 , 2006, J. Comput. Aided Mol. Des..
[59] K. Jacobson,et al. Adenosine receptors as therapeutic targets , 2006, Nature Reviews Drug Discovery.
[60] William J. Allen,et al. Practical Considerations for Building GROMOS-Compatible Small-Molecule Topologies , 2010, J. Chem. Inf. Model..
[61] D. van der Spoel,et al. GROMACS: A message-passing parallel molecular dynamics implementation , 1995 .
[62] K. Schulten,et al. Principal Component Analysis and Long Time Protein Dynamics , 1996 .
[63] Tod D Romo,et al. Block Covariance Overlap Method and Convergence in Molecular Dynamics Simulation. , 2011, Journal of chemical theory and computation.
[64] B M Pettitt,et al. A sampling problem in molecular dynamics simulations of macromolecules. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[65] A. Leslie,et al. Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation , 2011, Nature.
[66] P. Biggin,et al. Molecular Dynamics Simulations of the Ligand-binding Domain of an N-Methyl-d-aspartate Receptor* , 2006, Journal of Biological Chemistry.
[67] J. Ballesteros,et al. Activation of the β2-Adrenergic Receptor Involves Disruption of an Ionic Lock between the Cytoplasmic Ends of Transmembrane Segments 3 and 6* , 2001, The Journal of Biological Chemistry.
[68] H. Berendsen,et al. Essential dynamics of proteins , 1993, Proteins.
[69] Berk Hess,et al. LINCS: A linear constraint solver for molecular simulations , 1997, J. Comput. Chem..
[70] L. Pardo,et al. Crystal structure of the μ-opioid receptor bound to a morphinan antagonist , 2012, Nature.
[71] R. Stevens,et al. The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.
[72] A. W. Schüttelkopf,et al. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. , 2004, Acta crystallographica. Section D, Biological crystallography.
[73] R. Abagyan,et al. Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.
[74] G Vriend,et al. WHAT IF: a molecular modeling and drug design program. , 1990, Journal of molecular graphics.
[75] Ruben Abagyan,et al. Structure of the human histamine H1 receptor complex with doxepin , 2011, Nature.
[76] Oliver P. Ernst,et al. Crystal Structure of Native Opsin: the G Protein-Coupled Receptor Rhodopsin in its Ligand-free State , 2008 .
[77] Albert C. Pan,et al. Activation mechanism of the β2-adrenergic receptor , 2011, Proceedings of the National Academy of Sciences.
[78] Cheng Zhang,et al. High-resolution Crystal Structure of Human Protease-activated Receptor 1 Bound to the Antagonist Vorapaxar Hhs Public Access , 2022 .
[79] J. Konopka,et al. Mutation of Pro-258 in transmembrane domain 6 constitutively activates the G protein-coupled alpha-factor receptor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[80] Ursula Rothlisberger,et al. Early steps of the intramolecular signal transduction in rhodopsin explored by molecular dynamics simulations. , 2002, Biochemistry.
[81] M. Mortrud,et al. The G protein-coupled receptor repertoires of human and mouse , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[82] M. Parrinello,et al. Polymorphic transitions in single crystals: A new molecular dynamics method , 1981 .
[83] Bryan L. Roth,et al. Structure of the human kappa opioid receptor in complex with JDTic , 2012, Nature.
[84] J M Thornton,et al. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. , 1995, Protein engineering.
[85] Bernhard Pfeiffer,et al. Over one hundred peptide-activated G protein-coupled receptors recognize ligands with turn structure. , 2005, Chemical reviews.
[86] Hugh Rosen,et al. Crystal Structure of a Lipid G Protein–Coupled Receptor , 2012, Science.
[87] Manfred Burghammer,et al. Structure of bovine rhodopsin in a trigonal crystal form. , 2003, Journal of molecular biology.
[88] R. Stevens,et al. Structure of an Agonist-Bound Human A2A Adenosine Receptor , 2011, Science.
[89] Manfred Burghammer,et al. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. , 2007, Nature.
[90] M. Freissmuth,et al. Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptors. , 2010, Current pharmaceutical design.
[91] William L. Jorgensen,et al. Journal of Chemical Information and Modeling , 2005, J. Chem. Inf. Model..
[92] F. Schröder,et al. The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancer , 2008, BJU international.
[93] C. Dourish,et al. Discovery of nonxanthine adenosine A2A receptor antagonists for the treatment of Parkinson’s disease , 2003, Neurology.
[94] Chris Oostenbrink,et al. A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force‐field parameter sets 53A5 and 53A6 , 2004, J. Comput. Chem..
[95] Junmei Wang,et al. GPCR Structure-Based Virtual Screening Approach for CB2 Antagonist Search , 2007, J. Chem. Inf. Model..
[96] P. Biggin,et al. Molecular dynamics simulations of the ligand-binding domain of the ionotropic glutamate receptor GluR2. , 2002, Biophysical journal.
[97] J. Shiloach,et al. Structure of the agonist-bound neurotensin receptor , 2012, Nature.